Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.

NCT01991197 is registered in ClinicalTrials.gov with University College Dublin as lead sponsor.

NCT NCT01991197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01991197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
Lead sponsor
University College Dublin
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2014
Completion date
January 31, 2016
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis, type 2 diabetes mellitus